학술논문
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
Document Type
Artikel
Author
Barosi, G; Tefferi, A; Besses, C; Birgegard, G; Cervantes, F; Finazzi, G; Gisslinger, H; Griesshammer, M; Harrison, C; Hehlmann, R; Hermouet, S; Kiladjian, JJ; Kroger, N; Mesa, R; Mc Mullin, MF; Pardanani, A; Passamonti, F; Samuelsson, J; Vannucchi, AM; Reiter, A; Silver, RT; Verstovsek, S; Tognoni, G; Barbui, T
Source
Leukemia. 29(1):20-26
Subject
Language
English
English
English
ISSN
1476-5551